Adsilico redefines medical device innovation.
Adsilico has raised $4.4M in total funding. The most recent round was Seed. The last funding was announced in February 2024.
Adsilico's investors include Northern Gritstone, Parkwalk Advisors.
Adsilico is headquartered in Leeds, United Kingdom.
Adsilico redefines medical device innovation.
Adsilico is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Adsilico — Funding & Investors." VCBacked, February 26, 2024, https://www.vcbacked.co/company/adsilico. Accessed July 31, 2026.
VCBacked. (2024). Adsilico — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/adsilico
{{cite web |title=Adsilico — Funding & Investors |url=https://www.vcbacked.co/company/adsilico |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated